A biochemist by training, Chris De Jonghe is the current valorization director at the Dutch Oncode Institute for cancer research.
Previously, De Jonghe worked for more than 10 years in the tech transfer team of the Flanders Institute for Biotechnology (VIB), where she was involved in research collaborations, IP licensing and new venture creation. She used to be the head of Life Sciences & Care and group manager of Venture Capital at investment company PMV, where she was a member of its management committee.
De Jonghe obtained her PhD in the field of neurodegeneration and holds a law degree as well. She serves on the boards of several operational life sciences companies, investment funds and cluster organizations.